HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Hematology and Medical Oncology
Languages: English, Farsi and French
Locations: Manchester, CT and West Hartford, CT
Call West Hartford, CT: (860) 527-5803
Call Manchester, CT: (860) 646-0670
Mohammad Pazooki, MD, is a medical oncologist and hematologist with the Regional Cancer Care Associates (RCCA) team. He treats patients at locations in West Hartford and Manchester, Connecticut, helping them manage and overcome a range of cancer types and hematology conditions. Dr. Pazooki has over 26 years of experience in the medical field, so patients trust that their care is in knowledgeable hands. Reach out to RCCA today to schedule an appointment with Dr. Pazooki.
Like many physicians at RCCA, Dr. Pazooki has expertise in handling a wide array of cancer types. His special interest is in pancreatic cancer and pancreatic neoplasms, which are benign or cancerous growths in the pancreas. He is also competent with benign blood disorders and malignant blood disorders (blood cancers).
Dr. Pazooki works with an array of cutting-edge cancer treatments, including chemotherapy, targeted therapy, and immunotherapy. He also performs bone marrow aspirations as needed. This procedure can be used to diagnose a blood condition or to transplant stem cells as a treatment for many types of cancer.
While completing his residency in Internal Medicine at Huron Hospital, Dr. Pazooki also completed one year of Chief Residency.
Medical school: Tehran University of Medical Sciences, 1993
Residency: Huron Hospital, Internal Medicine, 2008
Fellowship: University of Connecticut Health Center, Oncology, 2012
Board certifications: Internal Medicine, Hematology, and Medical Oncology
Call West Hartford, CT: (860) 527-5803
Call Manchester, CT: (860) 646-0670
“I wanted to be an oncologist because I am deeply committed to making a difference,” says Dr. Pazooki. Cancer is a challenging diagnosis to live with. It does not only affect the body; it also brings a significant emotional and psychological burden to patients who might be concerned about a dangerous disease, demanding treatments, and a potentially uncertain outcome. During this difficult time, Dr. Pazooki strives “to be a source of support, hope, and healing for patients and their families.”
Cancer affects more than the body, and as an oncologist, Dr. Pazooki acts as more than a physician. He is also a guide. He educates patients and their families, assisting them in making complex care decisions. He uses his knowledge to deliver cutting-edge, compassion-driven treatments to help patients achieve the best possible outcomes.
Dr. Pazooki also advocates for advancements in cancer research. Now is an exciting time in the field of oncology. New discoveries are made almost daily, introducing cures for conditions that were previously always terminal. For diagnoses that are not curable, patient prognoses are better than ever. Treatments are becoming more effective with fewer downsides, and new ground is broken in molecular medicine and personalized care. By advocating for further discovery, Dr. Pazooki helps to push the field even further to create new and better options for his patients.
Dr. Pazooki serves patients at RCCA locations in West Hartford and Manchester, CT.
Phone:
Fax:
He also maintains hospital affiliations with Saint Francis Hospital and Manchester Memorial Hospital, two of the top treatment centers in his region.
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.